GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Price-to-Operating-Cash-Flow

Surgical Innovations Group (LSE:SUN) Price-to-Operating-Cash-Flow : (As of Jun. 02, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Price-to-Operating-Cash-Flow?

As of today (2024-06-02), Surgical Innovations Group's share price is £0.005. Surgical Innovations Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00. Hence, Surgical Innovations Group's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Surgical Innovations Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

LSE:SUN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.75   Med: 15.42   Max: 77.5
Current: 5

During the past 13 years, Surgical Innovations Group's highest Price-to-Operating-Cash-Flow Ratio was 77.50. The lowest was 3.75. And the median was 15.42.

LSE:SUN's Price-to-Operating-Cash-Flow is ranked better than
94.52% of 438 companies
in the Medical Devices & Instruments industry
Industry Median: 21 vs LSE:SUN: 5.00

Surgical Innovations Group's Cash Flow from Operations per share for the six months ended in Dec. 2023 was £0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Surgical Innovations Group was -100.00% per year.

During the past 13 years, Surgical Innovations Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.80% per year. The lowest was -45.00% per year. And the median was 20.60% per year.


Surgical Innovations Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Surgical Innovations Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group Price-to-Operating-Cash-Flow Chart

Surgical Innovations Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.50 16.50 - 16.00 -

Surgical Innovations Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Surgical Innovations Group's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Surgical Innovations Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's Price-to-Operating-Cash-Flow falls into.



Surgical Innovations Group Price-to-Operating-Cash-Flow Calculation

Surgical Innovations Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.005/0.001
=

Surgical Innovations Group's Share Price of today is £0.005.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Surgical Innovations Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group (LSE:SUN) Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.